Carcinoembryonic Antigen (CEA)
Catalogue Number: 151-10
Description
| Product Name | Carcinoembryonic Antigen |
| Source | Human Metastatic Liver Carcinoma |
| Catalogue Number | 151-10 |
| Purity | > 95% (SDS-PAGE) |
| Form | Liquid |
| Protein | Report mg/mL (A280) |
| Formulation | Solution in 20 mM tris, 100 mM sodium chloride, pH 7.4 with 0.05% sodium azide. |
| Related Products | 151-09 - Carcinoembryonic Antigen from human liver - Lyophilized 151-12 - anti-Human Carcinoembryonic Antigen polyclonal antibody 151-53 - Cancer Antigen 15-3 from human ascites fluid |
| Storage | -20°C |
| Recertification | 4 years |
| Infectious Disease Testing | Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV and HBsAg by FDA approved methods. |
| Synonyms | CEA, Carcinoembryonic antigen-related cell adhesion molecule 5, Meconium antigen 100, CD_antigen=CD66e |
| Gene | CEACAM5, CD66e, CEA |
| Molecular Weight | ~180,000 |
| Gene ID | 1048 |
| Accession No | P06731 |
Applications
Overview
Lee Biosolutions is a producer and supplier of high purity human Carcinoembryonic Antigen (CEA), a marker for bowel cancer, colorectal carcinoma, lung cancer research and diagnostic manufacturing.
Custom preparations, technical support, bulk quantities and aliquoting available, email Info@leebio.com for more details.
Serum tumor marker human Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production stops before birth. Therefore, serum tumor marker human CEA is not usually present in the blood of healthy adults, although levels are raised in heavy smokers.
Associated Cancer Types: Gastrointestinal, Cervix, Lung, Ovarian, Breast and Urinary Tract Cancer
Add to Cart
Lee Biosolutions, Inc
